Plasmacytoid dendritic cells promote rotavirus-induced human and murine B cell responses

Journal of Clinical Investigation

Volumn 123, Issue 6, 2013, Pages 2464-2474

  Deal, Emily M ^a,e   Lahl, Katharina ^a   Narváez, Carlos F ^a,b   Butcher, Eugene C ^a,c,d   Greenberg, Harry B ^a,c,d  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSIDAD SURCOLOMBIANA   (Colombia)

^c VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^d Palo Alto Institute for Research and Education   (United States)

^e BD BIOSCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD69 ANTIGEN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; RANTES; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ARTICLE; B LYMPHOCYTE; B LYMPHOCYTE ACTIVATION; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IN VITRO STUDY; IN VIVO STUDY; INTESTINE INFECTION; MOUSE; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; ROTAVIRUS; ROTAVIRUS INFECTION; VIRAL CLEARANCE; VIRUS SHEDDING;

ANIMALS; ANTIBODIES, VIRAL; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; B-LYMPHOCYTES; CELLS, CULTURED; CHEMOKINES; DENDRITIC CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, HUMORAL; INTERFERON TYPE I; LECTINS, C-TYPE; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; ROTAVIRUS; ROTAVIRUS INFECTIONS; VIRUS SHEDDING;

EID: 84878558515     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI60945     Document Type: Article

References (67)

1. Macpherson AJ, McCoy KD, Johansen F-E, Brandtzaeg P. The immune geography of IgA induction and function. Mucosal Immunol. 2008;1(1):11-22.
2. Cerutti A, Rescigno M. The biology of intestinal immunoglobulin A responses. Immunity. 2008; 28(6):740-750.
3. Mora J, et al. Generation of gut-homing IgA-secreting B cells by intestinal dendritic cells. Science. 2006; 314(5802):1157-1160.
4. Tezuka H, et al. Regulation of IgA production by naturally occurring TNF/iNOS-producing dendritic cells. Nature. 2007;448(7156):929-933.
5. Xu W, et al. Epithelial cells trigger frontline immunoglobulin class switching through a pathway regulated by the inhibitor SLPI. Nat Immunol. 2007; 8(3):294-303.
6. Strugnell RA, Wijburg OLC. The role of secretory antibodies in infection immunity. Nat Rev Immunol. 2010;8(9):656-667.
7. Wei M, Shinkura R, Doi Y, Maruya M, Fagarasan S, Honjo T. Mice carrying a knock-in mutation of Aicda resulting in a defect in somatic hypermutation have impaired gut homeostasis and compromised mucosal defense. Nat Immunol. 2011; 12(3):264-270.
8. Asselin-Paturel C, et al. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol. 2001;2(12):1144-1150.
9. Gilliet M, Cao W, Liu YJ. Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases. Nat Rev Immunol. 2008;8(8):594-606.
10. Katze MG, He Y, Gale M. Viruses and interferon: a fight for supremacy. Nat Rev Immunol. 2002; 2(9):675-687.
11. Lund JM, Linehan MM, Iijima N, Iwasaki A. Cutting edge: Plasmacytoid dendritic cells provide innate immune protection against mucosal viral infection in situ. J Immunol. 2006;177(11):7510-7514.
12. Swiecki M, Gilfillan S, Vermi W, Wang Y, Colonna M. Plasmacytoid dendritic cell ablation impacts early interferon responses and antiviral NK and CD8(+) T cell accrual. Immunity. 2010;33(6):955-966.
13. Ammann C, Messer R, Peterson K, Hasenkrug K. Lactate dehydrogenase- elevating virus induces systemic lymphocyte activation via TLR7-dependent IFNalpha responses by plasmacytoid dendritic cells. PLoS One. 2009;4(7):e6105.
14. Smitt J, Rudd B, Lukacs N. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J Exp Med. 2006;203(5):1153-1159.
15. Yoneyama M, et al. Plasmacytoid DCs help lymph node DCs to induce anti-HSV CTLs. J Exp Med. 2005; 202(3):425-435.
16. Cerutti A, Qiao X, He B. Plasmacytoid dendritic cells and the regulation of immunoglobulin heavy chain class switching. Immunol Cell Biol. 2005; 83(5):554-562.
17. Jego G, Palucka AK, Blanck J-P, Chalouni C, Pascual V, Banchereau J. Plasmacytoid dendritic cells induce plasma cell differentiation through type I interferon and interleukin 6. Immunity. 2003; 19(2):225-234.
18. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity. 2001;14(4):461-470.
19. Varani S, et al. Human cytomegalovirus differentially controls B cell and T cell responses through effects on plasmacytoid dendritic cells. J Immunol. 2007;179(11):7767-7776.
20. Tezuka H, et al. Prominent role for plasmacytoid dendritic cells in mucosal T cell-independent IgA induction. Immunity. 2011;34(2):247-257.
21. Deal EM, Jaimes MC, Crawford SE, Estes MK, Greenberg HB. Rotavirus structural proteins and dsRNA are required for the human primary plasmacytoid dendritic cell IFNalpha response. PLoS Pathog. 2010;6(6):e1000931.
22. Sen A, et al. Innate immune response to homologous rotavirus infection in the small intestinal villous epithelium at single-cell resolution. Proc Natl Acad Sci U S A. 2012;109(50):20667-20672.
23. Franco MA, Greenberg HB. Role of B cells and cytotoxic T lymphocytes in clearance of and immunity to rotavirus infection in mice. J Virol. 1995; 69(12):7800-7806.
24. Jayashree S, Bhan MK, Kumar R, Bhandari N, Sazawal S. Protection against neonatal rotavirus infection by breast milk antibodies and trypsin inhibitors. J Med Virol. 1988;26(3):333-338.
25. Johansen K, Svensson L. Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA. Arch Virol. 1997;142(7):1491-1498.
26. Ruggeri FM, Greenberg HB. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture. J Virol. 1991;65(5):2211-2219.
27. Franco MA, Tin C, Greenberg HB. CD8+ T cells can mediate almost complete short-term and partial long-term immunity to rotavirus in mice. J Virol. 1997;71(5):4165-4170.
28. Marcelin G, Miller AD, Blutt SE, Conner ME. Immune mediators of rotavirus antigenemia clearance in mice. J Virol. 2011;85(15):7937-7941.
29. Kuklin N, et al. Protective intestinal anti-rotavirus B cell immunity is dependent on alpha 4 beta 7 integrin expression but does not require IgA antibody production. J Immunol. 2001;166(3):1894-1902.
30. Narvaez CF, et al. Human rotavirus specific IgM memory B cells have differential cloning efficiency and switch capactiy and play a role in antiviral immunity in vivo. J Virol. 2012;86(19):10829-10840.
31. Blutt SE, Warfield KL, Lewis DE, Conner ME. Early response to rotavirus infection involves massive B cell activation. J Immunol. 2002;168(11):5716-5721.
32. Blutt SE, Crawford S, Warfield KL, Lewis DE, Estes MK, Conner ME. The VP7 outer capsid protein of rotavirus induces polyclonal B-cell activation. J Virol. 2004;78(13):6974-6981.
33. Wang Y, et al. Rotavirus infection alters peripheral T-cell homeostasis in children with acute diarrhea. J Virol. 2007;81(8):3904-3912.
34. Narvaez CF, Franco MA, Angel J, Morton JM, Greenberg HB. Rotavirus differentially infects and polyclonally stimulates human B cells depending on their differentiation state and tissue of origin. J Virol. 2010;84(9):4543-4555.
35. Kumagai Y, et al. Alveolar macrophages are the primary interferon-alpha producer in pulmonary infection with RNA viruses. Immunity. 2007; 27(2):240-252.
36. Lande R, Gilliet M. Plasmacytoid dendritic cells: key players in the initiation and regulation of immune responses. Ann N Y Acad Sci. 2010;1183:89-103.
37. Siegal FP, et al. The nature of the principal type 1 interferon-producing cells in human blood. Science. 1999;284(5421):1835-1837.
38. Asselin-Paturel C, Brizard G, Pin J-J, Briere F, Trinchieri G. Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody. J Immunol. 2003; 171(12):6466-6477.
39. Feng N, Burns JW, Bracy L, Greenberg HB. Comparison of mucosal and systemic humoral immune responses and subsequent protection in mice orally inoculated with a homologous or a heterologous rotavirus. J Virol. 1994;68(12):7766-7773.
40. Burns JW, Siadat-Pajour M, Krishnaney AA, Greenberg HB. Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity. Science. 1996;272(5258):104-107.
41. Feng N, Vo PT, Chung D, Vo TV, Hoshino Y, Greenberg HB. Heterotypic protection following oral immunization with live heterologous rotaviruses in a mouse model. J Infect Dis. 1997;175(2):330-341.
42. McNeal MM, Barone KS, Rae MN, Ward RL. Effector functions of antibody and CD8+ cells in resolution of rotavirus infection and protection against reinfection in mice. Virology. 1995;214(2):387-397.
43. Blasius AL, Cella M, Maldonado J, Takai T, Colonna M. Siglec-H is an IPC-specific receptor that modulates type I IFN secretion through DAP12. Blood. 2006;107(6):2474-2476.
44. Poeck H, et al. Plasmacytoid dendritic cells, antigen, and CpG-C license human B-cells for plasma cell differentiation and immunoglobulin production in the absence of T-cell help. Blood. 2004; 103(8):3058.
45. Bekeredjian-Ding IB, et al. Plasmacytoid dendritic cells control TLR7 sensitivity of naive B-cells via type I IFN. J Immunol. 2005;174(7):4043-4050.
46. Green NM, et al. Murine B cell response to TLR7 ligands depends on an IFN-β feedback loop. J Immunol. 2009;183(3):1569-1576.
47. Thibault DL, Graham KL, Lee LY, Balboni I, Hertzog PJ, Utz PJ. Type I interferon receptor controls B cell expression of nucleic acid-sensing Tolllike receptors and autoantibody production in a murine model of lupus. Arthritis Res Ther. 2009; 11(4):R112.
48. Chang WL, Coro ES, Rau FC, Xiao Y, Erle DJ, Baumgarth N. Influenza virus infection causes global respiratory tract B cell response modulation via innate immune signals. J Immunol. 2007; 178(3):1457-1467.
49. Coro ES, Chang WL, Baumgarth N. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J Immunol. 2006;176(7):4343-4351.
50. Purtha WE, Chachu KA, Virgin HW 4th, Diamond MS. Early B-cell activation after West Nile virus infection requires alpha/beta interferon but not antigen receptor signaling. J Virol. 2008; 82(22):10964-10974.
51. Woods A, et al. Influenza virus-induced type I interferon leads to polyclonal B-cell activation but does not break down B-cell tolerance. J Virol. 2007; 81(22):12525-12534.
52. Burns JW, Krishnaney AA, Vo PT, Rouse RV, Anderson LJ, Greenberg HB. Analyses of homologous rotavirus infections in the mouse model. Virology. 1995; 207(1):143-153.
53. Zhang J, et al. Characterization of Siglec-H as a novel endocytic receptor expressed on murine plasmacytoid dendritic cell precursors. Blood. 2006; 107(9):3600-3608.
54. Bernstein DI, Ziegler JM, Ward RL. Rotavirus fecal IgA antibody response in adults challenged with human rotavirus. J Med Virol. 1986;20(4):297-304.
55. O'Neal CM, Harriman GR, Conner ME. Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A. J Virol. 2000;74(9):4102-4109.
56. Ruggeri FM, Johansen K, Basile G, Kraehenbuhl J-P, Svensson L. Antirotavirus immunoglobulin a neutralizes virus in vitro after transcytosis through epithelial cells and protects infant mice from diarrhea. J Virol. 1998;72(4):2708-2714.
57. Corthesy B, et al. Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion. J Virol. 2006;80(21):10692-10699.
58. Feng N, et al. Inhibition of rotavirus replication by a non-neutralizing, rotavirus VP-specific IgA mAb. J Clin Invest. 2002;109(9):1203-1213.
59. Velazquez FR, et al. Serum antibody as a marker of protection against natural rotavirus infection and disease. J Infect Dis. 2000;182(6):1602-1609.
60. Heer AK, et al. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J Immunol. 2007;178(4):2182-2191.
61. Zhu J, Huang X, Yang Y. Type I IFN signaling on both B and CD4 T cells is required for protective antibody response to adenovirus. J Immunol. 2007; 178(6):3505-3510.
62. Contractor N, Louten J, Kim L, Biron CA, Kelsall BL. Cutting edge: Peyer's patch plasmacytoid dendritic cells (pDCs) produce low levels of type I interferons: possible role for IL-10, TGFbeta, and prostaglandin E2 in conditioning a unique mucosal pDC phenotype. J Immunol. 2007;179(5):2690-2694.
63. Fenaux M, Cuadras MA, Feng N, Jaimes M, Greenberg HB. Extraintestinal spread and replication of a homologous EC rotavirus strain and a heterologous rhesus rotavirus in BALB/c mice. J Virol. 2006; 80(11):5219-5232.
64. Cuadras MA, Feigelstock DA, An S, Greenberg HB. Gene expression pattern in Caco-2 cells following rotavirus infection. J Virol. 2002;76(9):4467-4482.
65. Hoshino Y, Wyatt RG, Greenberg HB, Flores J, Kapikian AZ. Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization. J Infect Dis. 1984;149(5):694-702.
66. Wei C, Jung J, Sanz I. OMIP-003: phenotypic analysis of human memory B cells. Cytometry A. 2011; 79(11):894-896.
67. Warfield KL, et al. Induction of humoral and CD8+ T cell responses are required for protection against lethal Ebola virus infection. J Immunol. 2005; 175(2):1184-1191.